Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hodgkin Disease × Sirolimus × 90 days × Clear all

Sponsor

Conditions

Hematologic Neoplasms 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma 4 Leukemia, Myeloid, Acute 4 Rhabdomyosarcoma 3 Neoplasms 3 Sarcoma, Ewing 2 Sarcoma 2 Rhabdoid Tumor 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Neuroblastoma 2 Neoplasms, Germ Cell and Embryonal 2 Myelodysplastic Syndromes 2 Melanoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Bronchiolitis Obliterans Syndrome 2 Brain Neoplasms 2 Wilms Tumor 1 Waldenstrom Macroglobulinemia 1 Tufted angioma 1 Tuberous Sclerosis 1 Thrombocytopenia 1 Skin Neoplasms 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Refractory Solid Tumors in Children 1 Recurrence 1 Pseudomyxoma Peritonei 1 Pinealoma 1 PRETEXT I Hepatoblastoma 1

Interventions

Cyclophosphamide 11 pembrolizumab 7 fludarabine 7 fludarabine phosphate 6 Doxorubicin 6 Vinblastine 5 Gemcitabine 5 Filgrastim 5 Dacarbazine 5 Brentuximab Vedotin 5 Bleomycin 5 Nivolumab 4 Mycophenolic Acid 4 Magnetic Resonance Spectroscopy 4 Granulocyte Colony-Stimulating Factor 4 Etoposide 4 Vincristine 3 Rituximab 3 Prednisone 3 Melphalan 3 Cisplatin 3 pegfilgrastim 2 Whole-Body Irradiation 2 Vinorelbine 2 Thiotepa 2 Tacrolimus 2 Specimen Handling 2 Radiotherapy 2 Prednisolone 2 Mesna 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡